Harpreet Singh

Mr. Harpreet Singh

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
HSHarpreet Singh
Harpreet Singh
MKManpreet Kaur
Manpreet Kaur
HKHarpreet Kaur
Harpreet Kaur
ISIndu Sharma
Indu Sharma
ABAnmol Bhandari
Anmol Bhandari
PSPalwinder Singh
Palwinder Singh

Verified
Journal Article
Open access
PDF file
MDMichael Oluwatoyin Daniyan
Michael Oluwatoyin Daniyan
HSHarpreet Singh
Harpreet Singh
Gregory L. BlatchGregory L. Blatch
Gregory L. Blatch
Plasmodium knowlesi is a zoonotic form of human malaria, the pathology of which is poorly understood. While the J domain protein (JDP) family has been extensively studied in Plasmodium falciparum, and shown to contribute to malaria pathology, there is currently very limited information on the P. knowlesi JDPs (PkJDPs). This review provides a critical analysis of the literature and publicly available data on PkJDPs. Interestingly, the P. knowlesi genome encodes at least 31 PkJDPs, with well over half belonging to the most diverse types which contain only the signature J domain (type IIIs, 19) or a corrupted version of the J domain (type IVs, 2) as evidence of their membership. The more typical PkJDPs containing other domains typical of JDPs in addition to the J domain are much fewer in number (type IIs, 8; type Is, 2). This study indentifies PkJDPs that are potentially involved in: folding of newly synthesized or misfolded proteins within the P. knowlesi cytosol (a canonical type I and certain typical type IIs); protein translocation (a type III) and folding (a type II) in the ER; and protein import into mitochondria (a type III). Interestingly, a type II PkJDP is potentially exported to the host cell cytosol where it may recruit human HSP70 for the trafficking and folding of other exported P. knowlesi proteins. Experimental studies are required on this fascinating family of proteins, not only to validate their role in the pathology of knowlesi malaria, but also because they represent potential anti-malarial drug targets.

30 May 2026
Verified
Book Chapter
Open access
TATanveer Ahmad
Tanveer Ahmad
BABushra A. Alhammadi
Bushra A. Alhammadi
SAShaikha Y. Almaazmi
Shaikha Y. Almaazmi
SASahar Arafa
Sahar Arafa
Gregory L. BlatchGregory L. Blatch
Gregory L. Blatch
HSHarpreet Singh
Harpreet Singh
From 2000 to 2019, the global malaria death toll fell from 864,000 to 576,000 deaths; however, progress on reducing this toll has since slowed, with the COVID-19 pandemic contributing to an increase in the mortality rate since 2020. The emergence of widespread resistance in the major malaria parasite (Plasmodium falciparum) to first-line treatment drugs has highlighted the need for new antimalarials and smarter drug delivery strategies. Nevertheless, recent successes of the first malaria vaccines (RTS,S/AS01 and R21/MM) have renewed the promise of widely applicable vaccines in the future. Since 2015, the Eastern Mediterranean Region has experienced an overall increase in malaria cases and deaths. In the Arabian Peninsula, while most of the Gulf Cooperation Council (GCC) countries have been declared free of indigenous malaria (Bahrain, Kuwait, Qatar, and the United Arab Emirates), malaria is still endemic in two GCC countries (Saudi Arabia and Oman) and their neighbors (Yemen). Furthermore, a number of factors threaten malaria control in this region, especially antimalarial drug resistance, the emergence of highly invasive mosquito species, increasing average temperatures, and imported malaria. In this review, we assess the current worldwide status of malaria before providing a critical evaluation of the malaria situation in the GCC countries.

26 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
TATanveer Ahmad
Tanveer Ahmad
BABushra A. Alhammadi
Bushra A. Alhammadi
SAShaikha Y. Almaazmi
Shaikha Y. Almaazmi
SASahar Arafa
Sahar Arafa
Gregory L. BlatchGregory L. Blatch
Gregory L. Blatch
HSHarpreet Singh
Harpreet Singh
The human malaria parasite, Plasmodium falciparum, accounts for more than 500,000 deaths worldwide per year. From 2000 to 2019, the malaria global death toll fell from 864,000 to 576,000 deaths; however, progress on reducing this toll has since slowed, with the COVID-19 pandemic contributing to an increase in the mortality rate since 2020. The emergence of widespread resistance in P. falciparum to first-line treatment drugs has highlighted the need for new antimalarial drugs, and smarter approaches, including better combination therapies and mass drug administration. Nevertheless, recent successes of the first malaria vaccine (RTS,S/AS01) and the approval of a second (R21/MM), have renewed the promise of widely applicable vaccines in the future. Since 2015, the Eastern Mediterranean Region has experienced an overall increase in malaria cases and deaths. In the Arabian Peninsula, while most of the Gulf Cooperation Council (GCC) countries have been declared free of indigenous malaria (Bahrain, Kuwait, Qatar, and the United Arab Emirates), malaria is still endemic in two GCC countries (Saudi Arabia and Oman) and its neighbors (Yemen). Furthermore, a number of factors threaten malaria control in this region, at the level of the parasite (antimalarial drug resistance), the mosquito (the emergence of highly invasive species), the environment (climate change and increasing average temperatures), and society (imported malaria). In this review, we assess the current world-wide status of malaria in terms of public health, prevention and treatment, before providing an Arabian regional perspective, with a critical evaluation of the malaria situation in the GCC countries.

17 October 2026
Verified
Book Chapter
Closed access
JKJaspreet Kaur
Jaspreet Kaur
HSHarpreet Singh
Harpreet Singh
Personalization has always been an important aspect of business and with the popularization of e-commerce as well as with the advances in technology; personalization has become vital to achieve customer interest, engagement, satisfaction and loyalty, positively impacting the sales. Recommendation systems act as a key component of the entire personalization cycle by reducing the information overload and recommending items as per the interest of the customer and helping the customer in decision making. Recommendation systems have been evolved from rule-based to Artificial Intelligence (AI)- and Machine Learning (ML)-based systems. The introduction of Generative AI has taken personalization to the next level. However, excessive use of AI may lead to homogeneity in recommendation leading to bias in decision making and affecting diversity of recommendations. AI-based recommendation systems need to strike a right balance in personalization and consumer behavior in order to achieve more realistic and sustainable personalization goals.

9 September 2020
Verified
Book Chapter
Closed access
PDF file
HSHarpreet Singh
Harpreet Singh
PSPurnima Sharma
Purnima Sharma
RKRupinder Preet Kaur
Rupinder Preet Kaur
DTDiksha Thakur
Diksha Thakur
PKPardeep Kaur
Pardeep Kaur